Orbus Therapeutics Receives U.S. Patent for Eflornithine Formulations
PALO ALTO, Calif., Dec. 23, 2020 (GLOBE NEWSWIRE) -- Orbus Therapeutics Inc., a private, late-stage biopharmaceutical company focused on the development and commercialization of therapies that treat rare diseases, announced that it has been granted patent …